Parental Support Intervention in an Advanced Oncological Context (NCT07341815) | Clinical Trial Compass
RecruitingNot Applicable
Parental Support Intervention in an Advanced Oncological Context
Belgium120 participantsStarted 2022-05-27
Plain-language summary
This prospective, two-arm randomized trial compares a psycho-educational program to a psycho-educational and experiential program for parents with advanced cancer. These two interventions aim to support parent-child communication about cancer, but we hypothesize that the combined intervention will be more effective for all studied communication variables.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Metastatic cancer, recurrence of cancer or certain types of hematological cancer (chronic disease, acute leukemia, multiple myeloma or lymphoma recurrence)
* Have at least one child aged between 10 and 25 years
* Wish to benefit from a psychological intervention about communication with their children about cancer or its consequences
* Able to read and speak French
* Accept to give their written informed consent
Exclusion Criteria:
* Severe neurological disorder
* Severe psychiatric disorder
* (Pre-)terminal phase of cancer disease
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Frequency of parental communication with their children about cancer or its consequences
Timeframe: Weeks 2 to 26 (weekly assessment).
2
Quality of parental communication with their children about cancer or its consequences
Timeframe: Weeks 2 to 26 (weekly assessment).
3
Parental communication difficulties
Timeframe: Baseline (T1), week 12 (T2) and week 26 (T3).
4
Parental self-efficacy regarding the communication with their children about cancer or its consequences
Timeframe: Baseline (T1), week 12 (T2) and week 26 (T3).
5
Participants' communication behaviors
Timeframe: Baseline (T1), week 12 (T2) and week 26 (T3).
6
Theoretical knowledge about the cancer-related concerns of children of different ages
Timeframe: Baseline (T1), week 12 (T2) and week 26 (T3).